GSK269962A
GSK269962A (GSK 269962) is a potent ROCK inhibitor with IC50s of 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively. GSK269962A has anti-inflammatory and vasodilatory activities[1].
Product Specifications
CAS Number
[850664-21-0]
Product Name Alternative
GSK 269962
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ROCK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton; Stem Cell/Wnt; TGF-beta/Smad
Applications
COVID-19-anti-virus
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/GSK269962A.html
Purity
99.83
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CCN1C2=CC(OC3=CC=CC(NC(C4=CC=C(OCCN5CCOCC5)C=C4)=O)=C3)=NC=C2N=C1C6=NON=C6N
Molecular Formula
C29H30N8O5
Molecular Weight
570.60
Precautions
H302, H315, H319, H335
References & Citations
[1]Doe C, et al. Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities. J Pharmacol Exp Ther. 2007 Jan;320 (1) :89-98.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ROCK1; ROCK2
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Influenza A virus (H1N1) HA/Hemagglutinin Protein (C-6His, Influenza A virus (A/WSN/1933 (H1N1) ) )
